Nassif Mikheal
Transaction: 08/04/2026
BUY
Change
+370
Price
$11.81
Filing
08/06/2026
Type
BUY
Neogen Corporation
NEOG • Medical - Diagnostics & Research
$11.83
▲ +0.19 (+1.63%)
Current price
EarningsLatest report: May 31, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$2.58B
Growth
7.8%
Cash Flow
2/5
Trend
Volatile
Evidence
Positive free cash flow · 0.68Manageable debt level · 0Healthy liquidity · 3.82Weak profitability
Financial data as of: May 31, 2026, 12:00 AM UTCLast earnings update: May 31, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 2:03 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$11.83
Change1.63%
Shares Out217.70M
Market Cap$2.58B
Enterprise Value$3.18B
52W Range4.78 - 12.85
Beta1.79
P/E-326.58
P/S2.96
P/B1.23
P/FCF-128.71
EV/Sales3.66
Price$11.83
Change1.63%
Shares Out217.70M
Market Cap$2.58B
Enterprise Value$3.18B
52W Range4.78 - 12.85
Beta1.79
P/E-326.58
P/S2.96
P/B1.23
P/FCF-128.71
EV/Sales3.66
EV/EBITDA23.01
EV/FCF-159.08
Earnings Yield-0.31%
FCF Yield-0.78%
Dividend Yield0.00%
Gross Margin46.93%
Oper. Margin-2.48%
Profit Margin-0.91%
Debt/Eq0.00
Current Ratio3.82
Quick Ratio2.91
Revenue 5Y7.77%
Target$13.00
Target Upside9.89%
Target Median$13.00
Target Range13.00 - 13.00
Volume96.93K
Avg Volume2.17M
EPS Surprise0.05
Investment DNA
How strong this company looks for long-term investors
56
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
89/100
Why this score▼
Positive free cash flow · 0.68Manageable debt level · 0Healthy liquidity · 3.82Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 11 analyst votes · 2026-09-04
68/100
Neutral
Bullish
5
Hold
5
Bearish
1
Price Target
2026-08-06
Low
$13.00
Mean
$13.00
Median
$13.00
High
$13.00
Insider Transactions
Recent executive and insider activity
Moylan John Patrick
Transaction: 06/03/2026
SELL
Change
-2,553
Price
$8.75
Filing
06/04/2026
Type
SELL
Rocklin Amy M
Transaction: 05/18/2026
SELL
Change
-35,183
Price
$9.29
Filing
05/19/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Nassif Mikheal | BUY | +370 | $11.81 | 08/04/2026 | 08/06/2026 |
| Moylan John Patrick | SELL | -2,553 | $8.75 | 06/03/2026 | 06/04/2026 |
| Rocklin Amy M | SELL | -35,183 | $9.29 | 05/18/2026 | 05/19/2026 |
| Rocklin Amy M | SELL | -10,241 | $9.29 | 05/18/2026 | 05/19/2026 |
| Moylan John Patrick | SELL | -4,558 | $9.53 | 05/04/2026 | 05/05/2026 |
| Moylan John Patrick | SELL | -1,568 | $9.53 | 05/04/2026 | 05/05/2026 |
| Stacey Jennifer Evans | BUY | +39,349 | $9.53 | 05/01/2026 | 05/04/2026 |
| Stacey Jennifer Evans | BUY | +89,520 | $9.53 | 05/01/2026 | 05/04/2026 |
| Stacey Jennifer Evans | OTHER | 0 | Not reported | 04/08/2026 | 04/13/2026 |
| Nassif Mikheal | BUY | +23 | $10.94 | 02/17/2026 | 02/17/2026 |
| Nassif Mikheal | BUY | +24 | $10.00 | 02/02/2026 | 02/02/2026 |
| Nassif Mikheal | BUY | +25 | $9.86 | 01/26/2026 | 02/02/2026 |
| Ranalli Tamara A. | BUY | +261,210 | $7.38 | 01/07/2026 | 01/29/2026 |
| Ranalli Tamara A. | OTHER | 0 | Not reported | 01/07/2026 | 01/26/2026 |
| Ranalli Tamara A. | BUY | +50,813 | $7.38 | 01/07/2026 | 01/26/2026 |
| Ranalli Tamara A. | BUY | +130,605 | $7.38 | 01/07/2026 | 01/26/2026 |
| Nassif Mikheal | BUY | +137 | $9.33 | 01/16/2026 | 01/16/2026 |
| Naemura David H. | SELL | -12,912 | $5.98 | 12/01/2025 | 12/02/2025 |
| Naemura David H. | SELL | -3,548 | $5.98 | 12/01/2025 | 12/02/2025 |
| Nassif Mikheal | BUY | +177 | $6.25 | 11/03/2025 | 11/07/2025 |